Supernus Pharmaceuticals Financial Activities - Other 2011-2025 | SUPN
Supernus Pharmaceuticals financial activities - other from 2011 to 2025. Financial activities - other can be defined as the net amount of items a company reports that are too small to report separately. Additionally, this field holds the sum of items a company reports that cannot be assigned to any other standardized field in the financing activities section of the Cash Flows Statement.
Supernus Pharmaceuticals Annual Financial Activities - Other
(Millions of US $) |
| 2024 |
$-3 |
| 2023 |
$-2 |
| 2022 |
$-23 |
| 2021 |
$N/A |
| 2020 |
$-1 |
| 2019 |
$N/A |
| 2018 |
$-38 |
| 2017 |
$N/A |
| 2016 |
$N/A |
| 2015 |
$N/A |
| 2014 |
$30 |
| 2013 |
$-5 |
| 2012 |
$-6 |
| 2011 |
$-3 |
| 2010 |
$-1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.872B |
$0.662B |
|
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
|
